retinal vein occlusion/nausea

Objective To determine the real-world short-term efficacy and safety of apremilast for Behçet's disease (BD).Methods The study included patients who received apremilast for refractory oral ulcers in addition to meeting International Study Group criteria for BD or the revised

Sixteen previously treated (with only one prior regimen) patients with histologically proven metastatic or locally recurrent colorectal carcinoma were treated with recombinant tumor necrosis factor (rTNF) administered by 30-minute i.v. infusions twice daily for 5 consecutive days every other week

OBJECTIVE To report the efficacy and safety of fluorescein angiography after oral administration of fluorescein solution in a large number of patients during a period of 8 years. METHODS A total of 1,787 patients (2,625 eyes) underwent fluorescein angiography after oral administration of sodium